MEDIZEN HUMANCARE Inc.

Equities

A236340

KR7236340006

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-09 pm EDT			5-day change	1st Jan Change
5,600 ^KRW	+0.18%		+10.89%	+40.00%

2023	MEDIZEN HUMANCARE Inc. announced that it has received KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	CI
2023	MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	CI

An individual and a company acquired 2.5% stake in Medizen Humancare Co.,Ltd. from K2 Liquidity Solution Fund managed by K2 Investment Partners LLC.

January 18, 2017

An individual and a company acquired 2.5% stake in Medizen Humancare Co.,Ltd. from K2 Liquidity Solution Fund managed by K2 Investment Partners LLC on January 16, 2017. K2 Liquidity Solution Fund sold 0.06 million shares and post completion holds 0.33 million shares. An individual and a company completed the acquisition of 2.5% stake in Medizen Humancare Co.,Ltd. from K2 Liquidity Solution Fund managed by K2 Investment Partners LLC on January 16, 2017.

Latest news about MEDIZEN HUMANCARE Inc.

MEDIZEN HUMANCARE Inc. announced that it has received KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	23-01-29	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	23-01-19	CI
PT Indo Medizen Sehat announced that it has received KRW 112.875 million in funding from MEDIZEN HUMANCARE Inc.	22-08-25	CI
PT Indo Medizen Sehat announced that it expects to receive KRW 112.875 million in funding from MEDIZEN HUMANCARE Inc.	22-08-24	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 3.469998 billion in funding	22-02-10	CI
MEDIZEN HUMANCARE Inc. announced that it has received KRW 999.992 million in funding	21-12-19	CI
MEDIZEN HUMANCARE Inc. announced that it has received KRW 1.499988 billion in funding	21-12-14	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 999.992 million in funding	21-12-09	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 1.499988 billion in funding	21-12-06	CI
HPio Co., Ltd. and BM International Holdings Co., Ltd. acquired 7.4% stake in MEDIZEN HUMANCARE Inc. for KRW 1.4 billion.	20-11-08	CI
Medizen Humancare Inc Co., Ltd announced that it has received KRW 1.999982 billion in funding from Woori Bank Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm	18-10-23	CI
Medizen Humancare Inc Co., Ltd announced that it expects to receive KRW 1.999982 billion in funding from Woori Bank Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm	18-10-15	CI
Medizen Humancare Co.,Ltd. announced that it has received KRW 1 billion in funding	17-02-16	CI
Medizen Humancare Co.,Ltd. announced that it expects to receive KRW 1 billion in funding	17-02-15	CI
Kiwoom Growth 15th Secondary Investment Fund managed by Kiwoom Investment Co., Ltd. acquired 1.96% stake in Medizen Humancare Co.,Ltd. for KRW 650 million.	17-01-23	CI
An individual and a company acquired 2.5% stake in Medizen Humancare Co.,Ltd. from K2 Liquidity Solution Fund managed by K2 Investment Partners LLC.	17-01-18	CI
Medizen Humancare Co.,Ltd. announced that it has received KRW 2.5 billion in funding	17-01-15	CI
Medizen Humancare Co.,Ltd. announced that it expects to receive KRW 2.5 billion in funding	17-01-12	CI
Samsung Pharmaceutical Co., Ltd. completed the sale of 17.13% stake in Medizen Humancare Co.,Ltd.	15-10-04	CI
Samsung Pharmaceutical Co., Ltd. agreed to sell 17.13% stake in Medizen Humancare Co.,Ltd. for KRW 2 billion.	15-08-31	CI

Chart MEDIZEN HUMANCARE Inc.

Duration

Period

More charts

Company Profile

Medizen Humancare Inc Co., Ltd is a Korea-based company mainly engaged in the provision of disease prediction services. The Company is involved in the provision of disease prediction services named My-Genome Check (M-CHECK). In addition, it is involved in the conduction of research projects, as well as the manufacturing and sale of saliva kits.

Sector

Biotechnology & Medical Research

Calendar

2024-06-11 - Investor Meeting

More about the company

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
MEDIZEN HUMANCARE INC.	+40.00%	9.35M
EXACT SCIENCES CORPORATION	-42.28%	7.92B
GUARDANT HEALTH, INC.	+10.68%	3.51B
IOVANCE BIOTHERAPEUTICS, INC.	-1.91%	2.18B
BGI GENOMICS CO., LTD.	-21.69%	1.97B
VERACYTE, INC.	-25.88%	1.58B
CAREDX, INC	+21.25%	792M
SEEGENE, INC.	-10.48%	690M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-29.90%	532M
CURIOX BIOSYSTEMS CO., LTD	-1.29%	303M

Bio Diagnostics & Testing